Clinical Trial Update: Dose Adaptation of Capecitabine Using Mobile Phone Toxicity Monitoring

View source ↗

Summary

This completed clinical trial evaluates dose adaptation of capecitabine guided by mobile phone toxicity monitoring in patients with metastatic colorectal cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer

Drugs mentioned

• Xeloda (capecitabine)

Snippet

Sponsor: University of Oxford | Conditions: Metastatic Colorectal Cancer, Metastatic Breast Cancer | Status: COMPLETED